Dr. Lincan Duan 段林灿
Chief Physician, Associate Professor
Department of Thoracic Surgery II, Yunnan Cancer Hospital, Kunming
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive surgery for lung cancer, esophageal cancer, and mediastinal tumors. Diagnosis and treatment of pulmonary nodules.
Dr. Duan graduated from Suzhou Medical College in 2000. Training in minimally invasive thoracic techniques was completed at West China Hospital, Sichuan University (2009) and Prince of Wales Hospital, Chinese University of Hong Kong (2012). Dr. Duan focuses on clinical and basic research in lung cancer, has led or participated in over 10 research projects, and authored numerous publications.
Professional roles
- Youth Committee Member, Thoracic Surgery Branch, Chinese Medical Doctor Association
- Standing Committee Member, Thoracic Surgery Branch, Yunnan Medical Doctor Association
- Vice Chair, Tumor Precision Therapy Professional Committee, Yunnan Anti-Cancer Association
- Leader, Chest Disease Diagnosis and Treatment Group, Oncology Branch, Yunnan Medical Doctor Association
Name order: in Chinese the family name comes first (Duan Lincan). Papers usually list the name as Lincan Duan or Duan L.
Selected publications
37 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- Med Oncol, 2026 (senior author): DNMT1 is associated with QDPR downregulation and chemotherapy response in lung adenocarcinoma. PubMed 42678580
- Front Cell Dev Biol, 2026 (senior author): Functions and mechanisms of circular RNAs in cancer stem cells and therapy resistance. PubMed 41993596
- Front Med (Lausanne), 2025 (senior author): Case Report: Pulmonary echinococcosis misdiagnosed as bronchogenic pulmonary cysts. PubMed 40166076
- Hereditas, 2025 (senior author): Exploring the association between rheumatoid arthritis and non-small cell lung cancer risk: a transcriptomic and drug target-based analysis. PubMed 40016789
- Front Mol Biosci, 2024 (senior author): Corrigendum: Comprehensive analysis of the prognostic and immunological role of PAFAH1B in pan-cancer. PubMed 39439529
- Front Cell Dev Biol, 2024 (senior author): Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis. PubMed 38645409
- Front Cell Dev Biol, 2022 (senior author): Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis. PubMed 36225317
- Front Oncol, 2022 (first author): Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1. PubMed 35600383
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion